Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.

Saved in:
Bibliographic Details
Title: Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression.
Authors: Zhang L; National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China., Liu Z; Department of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Ding Y; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China., Sun J; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China., Wu Y; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China., Shi J; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China., Su X; National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China., Jin K; National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China., Zeng H; Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China., Chang Y; Department of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Xu L; Department of Urology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhang W; Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China., Wang Z; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China., Liu H; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhu Y; Department of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Xu J; National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China. jjxufdu@fudan.edu.cn.
Source: British journal of cancer [Br J Cancer] 2026 May 15. Date of Electronic Publication: 2026 May 15.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-026-03473-3